Smaller Companies Next Frontier for FDA’s Voluntary Improvement Program

 
• By Elizabeth Orr
  
Smaller manufacturers may be reluctant to take on the FDA's Voluntary Improvement program, but those that do find benefits. (aboutstock/Shutterstock)

More from Compliance

More from Medtech Insight